LON:CTEA Catenae Innovation (CTEA) Share Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CTEA Stock Alerts GBX 0.55 0.00 (0.00%) (As of 03/5/2024) Add Compare Share Share Today's Range 0.50▼ 0.6050-Day Range 0.11▼ 0.6052-Week Range 0.50▼ 0.90Volume8,942 shsAverage Volume56,502 shsMarket Capitalization£313,555.00P/E RatioN/ADividend Yield0.86%Price TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Catenae Innovation alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Catenae InnovationCatenae Innovation Plc, together with its subsidiaries, provides financial technology and media publishing solutions primarily in the United Kingdom. The company offers COV-ID, a mobile application that contains a securely encrypted digital wallet, which provides demonstrable proof of an individual's Covid-19 status; OnSite WorkID, a digital wallet that allows the service provider to prove their identity and status to a third party; OnSite HospitalityID, an application that collects and stores customers details on each visit; OnSite TaskManager, a mobile management, inspection, and reporting solution; and OnSide, a centralized management tool for local government and community groups that offers scheduling of staff rotas, timesheet processing, attendee management, and reporting services. It also provides Sequestrum, a blockchain service that creates a permanent record of assets or transactions and provides the ability to act and report on activity relating to those assets or transactions. The company was formerly known as Milestone Group plc and changed its name to Catenae Innovation Plc in March 2018. The company was incorporated in 2003 and is based in London, the United Kingdom.Read More CTEA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CTEA Stock News HeadlinesNovember 30, 2023 | bbc.comInnovationSeptember 6, 2023 | marketwatch.comCatenae Innovation Says 51%-Owned Subsidiary Ceased Operations on Incurred LossesApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 2, 2023 | finance.yahoo.comCatenae Innovation Reports Full Year 2022 EarningsJanuary 26, 2023 | reuters.comCTEA.L - | Stock Price & Latest News | ReutersSeptember 30, 2022 | marketwatch.comCatenae Innovation Shares Fall After Trading Resumption; Posts Narrowed 1H LossMay 30, 2022 | marketwatch.comCatenae Innovation Says Financial Position Remains Unchanged Amid Trading SuspensionJanuary 5, 2022 | markets.businessinsider.comCatenae Innovation : Change of BrokerApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.August 9, 2021 | lse.co.ukCatenae wins new technology contract to work with Shetland space portAugust 9, 2021 | marketwatch.comCatenae Innovation Shares Rise on Order From UK Satellite Launch SiteAugust 2, 2021 | lse.co.ukCatenae shares surge amid new ProMake contract for data servicesSee More Headlines Receive CTEA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Catenae Innovation and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorComputer and Technology Industry Software - Infrastructure Sub-IndustryN/A Current SymbolLON:CTEA CUSIPN/A CIKN/A Webcatenaeinnovation.com Phone44 191 5808545FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on Equity-165.39% Return on Assets-46.50% Debt Debt-to-Equity Ratio1.74 Current Ratio0.53 Quick Ratio1.39 Sales & Book Value Annual Sales£35,402.00 Price / Sales8.86 Cash FlowGBX 0.33 per share Price / Cash Flow1.65 Book ValueGBX (1) per share Price / Book-0.55Miscellaneous Outstanding Shares57,010,000Free FloatN/AMarket Cap£313,555.00 OptionableNot Optionable Beta2.72 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Edward Guy Meyer (Age 65)CEO & Director Mr. John Farthing (Age 62)CFO, Company Secretary & Executive Director Mr. Alan SimpsonCTO & Member of Executive BoardMr. Paul ElliottSports & Corporate Social Responsibility Ambassador and Member of the Advisory BoardKey CompetitorsTechFinancialsLON:TECHCloudbuyLON:CBUYBig Sofa Technologies GroupLON:BSTDefenxLON:DFXSensyne HealthLON:SENSView All Competitors CTEA Stock Analysis - Frequently Asked Questions How have CTEA shares performed in 2024? Catenae Innovation's stock was trading at GBX 0.12 on January 1st, 2024. Since then, CTEA stock has increased by 378.3% and is now trading at GBX 0.55. View the best growth stocks for 2024 here. What other stocks do shareholders of Catenae Innovation own? Based on aggregate information from My MarketBeat watchlists, some companies that other Catenae Innovation investors own include Motive Television (MTV), Velocys (VLS), Vast Resources (VAST), Sareum (SAR), PowerHouse Energy Group (PHE), Mobile Streams (MOS), Hemogenyx Pharmaceuticals (HEMO), eve Sleep (EVE), EQTEC (EQT) and Ariad Pharmaceuticals (ARIA). How do I buy shares of Catenae Innovation? Shares of CTEA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CTEA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catenae Innovation Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.